CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory multiple...
Phase 1
Saint Louis, Missouri, United States and 5 other locations
The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....
Phase 2
Saint Louis, Missouri, United States and 56 other locations
and safety of bb2121 in participants with relapsed and refractory multiple myeloma (RRMM) (Cohort 1), in participants with RRMM who ...
Phase 2
Saint Louis, Missouri, United States and 25 other locations
This phase II clinical trial studies the addition of selinexor to lenalidomide in patients with multiple myeloma following transpla ...
Phase 2
Saint Louis, Missouri, United States
This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...
Phase 1
Saint Louis, Missouri, United States and 13 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Saint Louis, Missouri, United States and 31 other locations
The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...
Phase 2
Saint Louis, Missouri, United States and 9 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Saint Louis, Missouri, United States and 59 other locations
This is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of TNB-383B, a BCMA x CD3 T-cell engaging bisp...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 13 other locations
progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...
Phase 3
Saint Louis, Missouri, United States and 211 other locations
Clinical trials
Research sites
Resources
Legal